Workplace Surveillance: A new report highlights how AI-enabled tracking turns everyday workplace tech into detailed worker dossiers, raising fresh privacy and power-balance concerns. FDA & Biotech: Eisai and Biogen’s Leqembi IQLIK (subcutaneous lecanemab) is now available for mild Alzheimer’s treatment initiation, while the FDA accepted for priority review GSK’s dostarlimab-gxly for untreated dMMR/MSI-H stage II–III rectal cancer. Drug Policy & Peptides: The FDA is weighing whether to regulate six popular but experimental peptides through licensed compounding pharmacies, as millions reportedly use unapproved products. AI for Industry: Y Combinator-backed Neuron Industries launched a new industrial controller aimed at letting engineers write and change automation logic without deep control-engineering training. Energy & Climate Tech: Turkmen researchers say they’ve developed a soil biopreparation using native methane-oxidizing bacteria to neutralize methane emissions in industrial zones. Climate Risk & Infrastructure: A parametric coral reef insurance policy in Hawaii has paid out after Hurricane Lala, and a study links data-center heat to local “heat island” effects. Science Funding & Education: Namibia’s education and science committee urged predictable funding, stronger industry-university partnerships, and AI-hub lab investment. Research & Health: A study finds prenatal inflammation raises early ADHD risk, but sensitive caregiving in infancy can buffer it.